Health-Focused PE Firm 1315 Capital Closes $300M Fund
Philadelphia-based private investment firm 1315 Capital, which specializes in medical technology companies, has closed its second fund at more than $300 million, the company said Monday....To view the full article, register now.
Already a subscriber? Click here to view full article